Now some states _are_ close to 100%. Some are close to 60%. Investigating the differences in approach that lead to those differences in numbers mostly comes down to whether states prioritize vaccinating people or creating complicated rules and sticking to them.
When combined with things like this from https://www.theguardian.com/global-development/2021/feb/14/w... : "Instead we have a patchwork of approvals and I have 70m doses that I can’t ship because they have been purchased but not approved. They have a shelf life of six months; these expire in April.", it sure seems like a large part of the apparent supply bottleneck is self-inflicted. Some basic "if it's approved in another G-8 country (or whatever criterion you want to pick) we should auto-approve it here" logic would probably significantly help with this sort of thing....
Now some states _are_ close to 100%. Some are close to 60%. Investigating the differences in approach that lead to those differences in numbers mostly comes down to whether states prioritize vaccinating people or creating complicated rules and sticking to them.
When combined with things like this from https://www.theguardian.com/global-development/2021/feb/14/w... : "Instead we have a patchwork of approvals and I have 70m doses that I can’t ship because they have been purchased but not approved. They have a shelf life of six months; these expire in April.", it sure seems like a large part of the apparent supply bottleneck is self-inflicted. Some basic "if it's approved in another G-8 country (or whatever criterion you want to pick) we should auto-approve it here" logic would probably significantly help with this sort of thing....